Pharma Group Says “No” To Expensive Gifts to Doctors Which Could Influence Their Drug Choices

Nolan and Auerbach — Fri, 05 Jan 2007 17:51:39 +0000

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a worldwide trade group said that under their revised ethics code that as of January 1, 2007, they were no longer permitted to provide expensive gifts to doctors. This change to the ethics code was the first in the past 10 years. Members of this trade group are no longer permitted to give physicians money or expensive gifts such as stays in luxury hotels or trips to golf resorts that might influence their prescription drug selections. IFPMA members include Pfizer, GlaxoSmithKline, Sanofi-Aventis, Eli Lilly, AstraZeneca, Merck and Novartis. Here’s to more reform!

For more information click here.

Pharma Has Its Nose In Clinical Trials

Nolan and Auerbach — Tue, 05 Dec 2006 15:05:52 +0000

A survey published in the New York Journal of Medicine found that more than a third of experts who oversee clinical trials at both medical schools and research hospitals have financial ties to pharmacutical and/or medical device companies. It was further found that some experts had a direct conflict of interest under federal rules; voting on or discussing clinical trials sponsored by companies they had relationships with or competitors of those very same companies. These experts may be part of review boards who are supposed to be insuring the scientific validity of clinical trials and safeguarding the safety of patient participants. Susan L. Rose, executive director of University of Southern California’s Office for the Protection of Research Subjects, said academic institutions had been reassessing their policies and discussing the need for mandatory disclosures.

To read more click here.

Pharma 101 - Pharmaceutical Fraud » Pharmaceutical companies

Pharma Group Says “No” To Expensive Gifts to Doctors Which Could Influence Their Drug Choices

Pharma Has Its Nose In Clinical Trials